Tandem Diabetes (TNDM) Tops Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Tandem Diabetes Care Reports Second Quarter 2015 Financial Results
July 30, 2015 4:30 PM EDTSAN DIEGO, July 30, 2015 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex Insulin Pumps, today reported its financial results for the quarter ended June 30, 2015.
In comparing the second quarter of 2015 to the same period of 2014:
Sales grew 53 percent to $15.7 million from $10.3 million Total pump shipments grew 49 percent to 3,331 pumps from 2,235 pumps Operating margin improved to negative 119 percent from negative 179 percentIn comparing the first six months of 2015 to the same period of... More
Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems
July 30, 2015 4:16 PM EDTSAN DIEGO, July 30, 2015 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex Insulin Pumps, today announced that it has entered into non-exclusive Development Agreements with Dexcom, Inc. to allow the integration of future generation Tandem insulin pumps with the Dexcom G5 and G6 continuous glucose monitoring ("CGM") systems.
"Integrating Tandem's next generation pump platform with Dexcom's future CGM systems is an important step in aligning our technologies to be used in automated insulin delivery applications," said Kim Blickenstaff,... More



